Developer docs
API playgroundTry for free, no card

Search company profiles

Northwell Cancer Institute

Full company profile

uuid0042tr5

Namestring
Northwell Cancer Institute
Legal namestring
Northwell Health
Company typeenum
Private
Founded yearstring
-
Descriptiontext

Northwell Cancer Institute is the oncology division of Northwell Health, the largest private nonprofit healthcare system in New York. It operates 13 or more cancer care locations across the greater New York metropolitan area — including Lake Success and the R.J. Zuckerberg Cancer Center — providing comprehensive cancer services spanning screening, diagnosis, second opinions, medical oncology, surgical oncology, radiation oncology, immunotherapy, genetic counseling, survivorship, and clinical trial enrollment. The Institute operates as a hospital-anchored, integrated delivery network rather than a standalone provider, and accepts Medicare, Medicaid, and most major commercial insurance plans, generating revenue under a fee-for-service reimbursement model tied to its parent system's payer contracts.

The Institute's technology stack is among the broadest in the region and includes the Gamma Knife Icon (the only deployment on Long Island for stereotactic radiosurgery), Varian Ethos with HyperSight adaptive radiation therapy, TrueBeam, Halcyon, and Trilogy linear accelerators, proton therapy delivered through a partnership, histotripsy (non-invasive liver and kidney tumor ablation, also only on Long Island), robotic and minimally invasive surgery platforms, and CAR-T cellular therapy under FACT accreditation. It has built in-house molecular diagnostics capability via a $3.2 million laboratory supporting next-generation sequencing, and has pursued partnerships with Cold Spring Harbor Laboratory for translational research, NRG Oncology for clinical trial access, and OPKO Health/BioReference for diagnostic collaboration.

The business model is fundamentally a regional, multi-site clinical service line within a $14 billion-plus health system. Revenue derives from procedure volumes across radiation, surgery, infusion, and inpatient oncology, supplemented by ancillary diagnostics and genetic counseling. There is no indication of a direct-to-consumer product, software, or licensing revenue stream; the Institute's economic profile is that of a capital-intensive, reimbursement-dependent provider organization whose competitive position is determined by clinical capabilities, accreditation, geographic footprint, and physician talent rather than by technology IP or subscription economics.

Short descriptiontext

Northwell Cancer Institute is the oncology division of Northwell Health, New York's largest healthcare system, operating 13 or more locations across the NY metro area to deliver comprehensive cancer care including radiation, surgery, immunotherapy, and clinical trials.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersLake Success, United States
HQ citystring
Lake Success
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices13 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
cancer treatment services, radiation oncology, surgical oncology, cancer screening, genetic counseling
Industry7 codes
1Ambulatory Oncology Centers (Outpatient Chemo/Radiation)
CodeHLAFABAIPrimaryYes
2Hospital-Integrated Cancer Centers (Acute Oncology Programs)
CodeHLAFAAAMPrimaryNo
3Medical Oncology
CodeHLAKAFABPrimaryNo
4Surgical Oncology
CodeHLAKAFAGPrimaryNo
5Genitourinary Oncology
CodeHLAKAFAMPrimaryNo
6Neuro-Oncology
CodeHLAKAFAHPrimaryNo
7Gynecologic Oncology
CodeHLAKAFAFPrimaryNo
NAICS code4 codes
  • Offices of Physicians62111
  • Ambulatory Health Care Services621
  • Specialty (except Psychiatric and Substance Abuse) Hospitals622310
  • Medical and Diagnostic Laboratories62151
SIC code4 codes
  • Services-Specialty Outpatient Facilities, Nec8093
  • Services-Health Services8000
  • Services-Offices & Clinics Of Doctors Of Medicine8011
  • Services-General Medical & Surgical Hospitals, Nec8062
Product category
Oncology Services
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model2 records
1Cancer Treatment Services
TypeProfessional Services
Description

Fee-for-service healthcare delivery model for cancer treatment including chemotherapy, radiation therapy, surgery, immunotherapy, and related cancer care services. Revenue generated through insurance reimbursements, government healthcare programs (Medicare, Medicaid), and patient payments.

cancer.northwell.edu
2Clinical Trials
TypeProfessional Services
Description

Research-based revenue from clinical trials, potentially including sponsored research agreements and grant funding for innovative cancer treatments.

cancer.northwell.edu
Marketing channels8 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales
Pricing details1 tier
1Standard cancer treatment services covered by insurance
ModelOtherBilling cadencePay-as-you-go
Notes

Services are billed through insurance with coverage varying by plan. Financial assistance and payment plans may be available. Price transparency tools are referenced but specific rates are not publicly listed.

cancer.northwell.edu
GTM typeB2C
B2C
Offering typeServices
Services
Brand1 of 4 records shown
1R.J. Zuckerberg Cancer Center
Description

Primary cancer center location at the Center for Advanced Medicine in Lake Success, NY

cancer.northwell.edu
+3 more records
Core offering1 text field

Northwell Cancer Institute is a comprehensive cancer care provider offering diagnosis, treatment, and supportive services across the greater New York metropolitan area. It delivers radiation therapy, chemotherapy, immunotherapy, surgical oncology, robotic surgery, genetic counseling, cancer screening, and clinical trials through a network of hospital-based cancer centers and radiation medicine facilities.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 2 values shown
  • Complete pathological response achieved in more than 50% of triple negative breast cancer cases following initial chemotherapy
+1 more record
Product overview1 text field

Northwell Cancer Institute is a comprehensive cancer care provider offering a full spectrum of cancer treatment services and advanced technologies. The institute operates as a multi-location network across Long Island, New York City, Westchester, Hudson Valley, and Connecticut. Core treatment services include medical oncology, radiation therapy, surgical oncology, immunotherapy, and genetic counseling. The institute differentiates itself through advanced radiation technology platforms including Varian Ethos with HyperSight (adaptive radiation therapy), Gamma Knife Icon, TrueBeam Radiotherapy System, Trilogy System, and proton therapy. Surgical services feature robotic surgery capabilities for multiple cancer types. Patient support is provided through dedicated nurse navigators and comprehensive screening programs. The digital patient experience is delivered through the MyNorthwell portal for appointment management, test results, and provider communication.

Product and service12 records
1Varian Ethos Radiation Therapy with HyperSight
CategoryTreatment Technology
Description

Advanced radiation therapy platform using real-time imaging and artificial intelligence to adapt treatment plans daily, targeting tumors precisely while avoiding healthy tissue. Available for cancer patients undergoing radiation therapy.

2Gamma Knife Icon
CategoryTreatment Technology
Description

Stereotactic radiosurgery for brain tumors, AVMs, and neurological conditions, delivering high-dose focused radiation without damaging surrounding healthy tissue. The only Gamma Knife Icon on Long Island.

3TrueBeam Radiotherapy System
CategoryTreatment Technology
Description

Hybrid linear accelerator system for pinpoint radiation therapy with advanced image guidance, delivering precise cancer treatment while protecting surrounding normal structures.

4Trilogy System
CategoryTreatment Technology
Description

Advanced radiotherapy platform combining real-time image guidance and beam delivery with breathing synchronization to precisely target tumors while minimizing radiation to healthy tissues.

5Proton Therapy
CategoryTreatment Technology
Description

External-beam radiation therapy that uses protons to treat cancer, offered in partnership in Somerset, New Jersey.

6Cancer Robotic Surgery
CategoryTreatment Technology
Description

Minimally invasive robotic-assisted surgery for prostate, kidney, colon, esophageal, liver, pancreas, cervical, lung, and thoracic cancers, offering less postoperative pain, lower infection risk, and improved recovery times.

7Immunotherapy
CategoryTreatment Service
Description

Biologic therapy using the body's immune system to fight cancer, including checkpoint inhibitors, adoptive T cell (CAR-T) therapy, and bispecific T cell engagers (BITE).

8Chemotherapy
CategoryTreatment Service
Description

Use of chemotherapeutic agents to kill or slow the growth of rapidly multiplying cancer cells, administered intravenously or orally.

9Genetic Counseling and Testing
CategoryDiagnostic Service
Description

Comprehensive genetic testing to detect inherited factors and gene mutations that increase risk for certain cancers, including BRCA1/BRCA2 and Lynch syndrome testing, with personalized risk assessment counseling.

10Cancer Navigation Program
CategorySupport Service
Description

Nurse navigator services providing personalized guidance through diagnosis, treatment, and recovery, including appointment coordination, emotional support, and connection to clinical trials.

11Cancer Screening Services
CategoryPrevention Service
Description

Comprehensive cancer screening and prevention resources including mammograms, colonoscopies, lung cancer screening, and free screenings for uninsured and underinsured individuals.

12MyNorthwell Patient Portal
CategoryDigital Service
Description

Digital patient experience platform for managing appointments, accessing test results, paying bills, and communicating with providers.

Scale indicator6 records

Each record includes

Type, Value, Description, Source

Partnership5 partners
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Research partnership for investigator-initiated clinical trials and access to leading-edge cancer research, contributing to innovative therapies and treatment advancements.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Strategic alliance for participation in clinical trials and access to novel therapies and diagnostic technologies in cancer care.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Partnership in NRG Oncology clinical trials, providing patients access to national cancer research studies and collaborative treatment approaches.

Strategic tierCoreTypeOthers
Description

Partnership to provide free cancer screening services for uninsured and underinsured individuals at multiple Northwell locations including LIJ, Queens, Staten Island, Suffolk, Westchester, and Hudson Valley.

5Connecticut Early Detection and Prevention Program
Strategic tierMinorTypeOthers
Description

Partnership to provide free cancer screenings in Danbury and Norwalk, Connecticut for eligible individuals.

cancer.northwell.edu
Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Large NCI-designated comprehensive cancer center operating multi-site cancer programs across California, Arizona, and Illinois. Comparable in being a high-volume, multi-modality community-integrated cancer delivery network with strong research and cellular therapy programs.

TypeDirect peer
Description

Buffalo-based standalone NCI-designated comprehensive cancer center. Comparable in being a high-volume, multi-modality cancer program with research depth, though operating in a different upstate NY geography.

TypeDirect peer
Description

The dominant standalone cancer center in the NYC metro. Comparable in offering comprehensive medical, surgical, and radiation oncology across multiple sites, and competes directly for tertiary and complex cancer referrals that NCI also targets.

TypeDirect peer
Description

NYC-based NCI-designated comprehensive cancer center offering medical oncology, radiation, surgery, CAR-T, and clinical trials across Manhattan and Brooklyn. Direct competitor for the same patient population NCI serves.

TypeRegional player
Description

New Jersey's largest cancer program and John Theurer Cancer Center partner. Comparable service breadth (radiation, surgical, cellular therapy) but primarily serves NJ patients, overlapping with NCI's NJ proton therapy partnership catchment.

TypeDirect peer
Description

NYC-based comprehensive cancer program offering the same modalities (radiation, surgery, immunotherapy, CAR-T, clinical trials). NCI actively hired from Mount Sinai (Kai Tsao), evidencing direct head-to-head competition for talent and patients.

TypeDirect peer
Description

Bronx-based NCI-designated cancer center operating as a multi-site program in the NYC metro. Overlaps with NCI on radiation, medical oncology, and surgical oncology in Westchester and the Bronx catchment.

TypeBroad incumbent
Description

Now part of City of Hope, this network operates destination cancer hospitals with comprehensive radiation, surgical, and medical oncology offerings—comparable in service model to Northwell Cancer Institute's multi-site delivery.

TypeDirect peer
Description

NYC-based NCI-designated cancer program at Columbia. Competes for complex cases, surgical oncology, and radiation therapy referrals in the same metro as Northwell.

TypeRegional player
Description

Philadelphia-based NCI-designated comprehensive cancer center with comparable radiation, surgical, CAR-T, and clinical trial portfolio. Regional rather than direct competitor given geography, but comparable in scale and academic depth.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers6 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI capability3 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature10 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles3 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance6 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Northwell Cancer Institute

Oncology Servicescancer.northwell.edu

Northwell Cancer Institute is the oncology division of Northwell Health, New York's largest healthcare system, operating 13 or more locations across the NY metro area to deliver comprehensive cancer care including radiation, surgery, immunotherapy, and clinical trials.

What Northwell Cancer Institute does

Northwell Cancer Institute is the oncology division of Northwell Health, the largest private nonprofit healthcare system in New York. It operates 13 or more cancer care locations across the greater New York metropolitan area — including Lake Success and the R.J. Zuckerberg Cancer Center — providing comprehensive cancer services spanning screening, diagnosis, second opinions, medical oncology, surgical oncology, radiation oncology, immunotherapy, genetic counseling, survivorship, and clinical trial enrollment. The Institute operates as a hospital-anchored, integrated delivery network rather than a standalone provider, and accepts Medicare, Medicaid, and most major commercial insurance plans, generating revenue under a fee-for-service reimbursement model tied to its parent system's payer contracts.

The Institute's technology stack is among the broadest in the region and includes the Gamma Knife Icon (the only deployment on Long Island for stereotactic radiosurgery), Varian Ethos with HyperSight adaptive radiation therapy, TrueBeam, Halcyon, and Trilogy linear accelerators, proton therapy delivered through a partnership, histotripsy (non-invasive liver and kidney tumor ablation, also only on Long Island), robotic and minimally invasive surgery platforms, and CAR-T cellular therapy under FACT accreditation. It has built in-house molecular diagnostics capability via a $3.2 million laboratory supporting next-generation sequencing, and has pursued partnerships with Cold Spring Harbor Laboratory for translational research, NRG Oncology for clinical trial access, and OPKO Health/BioReference for diagnostic collaboration.

The business model is fundamentally a regional, multi-site clinical service line within a $14 billion-plus health system. Revenue derives from procedure volumes across radiation, surgery, infusion, and inpatient oncology, supplemented by ancillary diagnostics and genetic counseling. There is no indication of a direct-to-consumer product, software, or licensing revenue stream; the Institute's economic profile is that of a capital-intensive, reimbursement-dependent provider organization whose competitive position is determined by clinical capabilities, accreditation, geographic footprint, and physician talent rather than by technology IP or subscription economics.

Northwell Cancer Institute firmographics

Firmographics
Name
Northwell Cancer Institute
Legal name
Northwell Health
Website
https://cancer.northwell.edu
Company type
Private
Operating status
Operating
Headcount range
11–50 employees
Short description
Northwell Cancer Institute is the oncology division of Northwell Health, New York's largest healthcare system, operating 13 or more locations across the NY metro area to deliver comprehensive cancer care including radiation, surgery, immunotherapy, and clinical trials.
Ownership category
akta.pro rank

Northwell Cancer Institute industry classification

Industry
Product category
Oncology Services
NAICS
Offices of Physicians (62111), Ambulatory Health Care Services (621), Specialty (except Psychiatric and Substance Abuse) Hospitals (622310), Medical and Diagnostic Laboratories (62151)
SIC
Services-Specialty Outpatient Facilities, Nec (8093), Services-Health Services (8000), Services-Offices & Clinics Of Doctors Of Medicine (8011), Services-General Medical & Surgical Hospitals, Nec (8062)
akta.pro primary industry
Ambulatory Oncology Centers (Outpatient Chemo/Radiation) (HLAFABAI)
akta.pro secondary industries
Hospital-Integrated Cancer Centers (Acute Oncology Programs) (HLAFAAAM), Medical Oncology (HLAKAFAB), Surgical Oncology (HLAKAFAG), Genitourinary Oncology (HLAKAFAM), Neuro-Oncology (HLAKAFAH), Gynecologic Oncology (HLAKAFAF)

Keywords

  • Cancer treatment services
  • Radiation oncology
  • Surgical oncology
  • Cancer screening
  • Genetic counseling

Where Northwell Cancer Institute is headquartered

Location

Headquarters

HQ city
Lake Success
HQ country
United States
HQ region
North America

Offices13 records

Markets served

Northwell Cancer Institute business model

Business model
GTM type
B2C
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales

Revenue model

  1. Cancer Treatment Services: Fee-for-service healthcare delivery model for cancer treatment including chemotherapy, radiation therapy, surgery, immunotherapy, and related cancer care services. Revenue generated through insurance reimbursements, government healthcare programs (Medicare, Medicaid), and patient payments.
  2. Clinical Trials: Research-based revenue from clinical trials, potentially including sponsored research agreements and grant funding for innovative cancer treatments.

Pricing tiers

ModelBillingPrice
OtherPay-as-you-goStandard cancer treatment services covered by insurance

Go-to-market motion1 record

Distribution channels4 records

Marketing channels8 records

Northwell Cancer Institute product offering

Product offering

Core offering

Northwell Cancer Institute is a comprehensive cancer care provider offering diagnosis, treatment, and supportive services across the greater New York metropolitan area. It delivers radiation therapy, chemotherapy, immunotherapy, surgical oncology, robotic surgery, genetic counseling, cancer screening, and clinical trials through a network of hospital-based cancer centers and radiation medicine facilities.

Product overview

Northwell Cancer Institute is a comprehensive cancer care provider offering a full spectrum of cancer treatment services and advanced technologies. The institute operates as a multi-location network across Long Island, New York City, Westchester, Hudson Valley, and Connecticut. Core treatment services include medical oncology, radiation therapy, surgical oncology, immunotherapy, and genetic counseling. The institute differentiates itself through advanced radiation technology platforms including Varian Ethos with HyperSight (adaptive radiation therapy), Gamma Knife Icon, TrueBeam Radiotherapy System, Trilogy System, and proton therapy. Surgical services feature robotic surgery capabilities for multiple cancer types. Patient support is provided through dedicated nurse navigators and comprehensive screening programs. The digital patient experience is delivered through the MyNorthwell portal for appointment management, test results, and provider communication.

Differentiator

Problem solved

Functional benefit

Brands

  • R.J. Zuckerberg Cancer Center: Primary cancer center location at the Center for Advanced Medicine in Lake Success, NY
  • Monter Cancer Center
  • Katz Women's Surgical Center
  • Imbert Cancer Center

Products and services

  • Varian Ethos Radiation Therapy with HyperSight Advanced radiation therapy platform using real-time imaging and artificial intelligence to adapt treatment plans daily, targeting tumors precisely while avoiding healthy tissue. Available for cancer patients undergoing radiation therapy.
  • Gamma Knife Icon Stereotactic radiosurgery for brain tumors, AVMs, and neurological conditions, delivering high-dose focused radiation without damaging surrounding healthy tissue. The only Gamma Knife Icon on Long Island.
  • TrueBeam Radiotherapy System Hybrid linear accelerator system for pinpoint radiation therapy with advanced image guidance, delivering precise cancer treatment while protecting surrounding normal structures.
  • Trilogy System Advanced radiotherapy platform combining real-time image guidance and beam delivery with breathing synchronization to precisely target tumors while minimizing radiation to healthy tissues.
  • Proton Therapy External-beam radiation therapy that uses protons to treat cancer, offered in partnership in Somerset, New Jersey.
  • Cancer Robotic Surgery Minimally invasive robotic-assisted surgery for prostate, kidney, colon, esophageal, liver, pancreas, cervical, lung, and thoracic cancers, offering less postoperative pain, lower infection risk, and improved recovery times.
  • Immunotherapy Biologic therapy using the body's immune system to fight cancer, including checkpoint inhibitors, adoptive T cell (CAR-T) therapy, and bispecific T cell engagers (BITE).
  • Chemotherapy Use of chemotherapeutic agents to kill or slow the growth of rapidly multiplying cancer cells, administered intravenously or orally.
  • Genetic Counseling and Testing Comprehensive genetic testing to detect inherited factors and gene mutations that increase risk for certain cancers, including BRCA1/BRCA2 and Lynch syndrome testing, with personalized risk assessment counseling.
  • Cancer Navigation Program Nurse navigator services providing personalized guidance through diagnosis, treatment, and recovery, including appointment coordination, emotional support, and connection to clinical trials.
  • Cancer Screening Services Comprehensive cancer screening and prevention resources including mammograms, colonoscopies, lung cancer screening, and free screenings for uninsured and underinsured individuals.
  • MyNorthwell Patient Portal Digital patient experience platform for managing appointments, accessing test results, paying bills, and communicating with providers.

Quantifiable outcome

  • Complete pathological response achieved in more than 50% of triple negative breast cancer cases following initial chemotherapy
  • +1 more outcomes

Companies that use Northwell Cancer Institute

Customer profile

Named customers6 records

Segments3 records

Ideal customer profiles3 records

Northwell Cancer Institute technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability3 records

Feature10 records

Northwell Cancer Institute partnerships and signals

Strategic signal

Partnerships

Five partnerships are on record, tiered core and minor.

  • Cold Spring Harbor LaboratorycoreStrategic or Co-development PartnerResearch partnership for investigator-initiated clinical trials and access to leading-edge cancer research, contributing to innovative therapies and treatment advancements.
  • OPKO HealthcoreStrategic or Co-development PartnerStrategic alliance for participation in clinical trials and access to novel therapies and diagnostic technologies in cancer care.
  • NRG OncologycoreStrategic or Co-development PartnerPartnership in NRG Oncology clinical trials, providing patients access to national cancer research studies and collaborative treatment approaches.
  • New York State Department of Health Cancer Services ProgramcoreOthersPartnership to provide free cancer screening services for uninsured and underinsured individuals at multiple Northwell locations including LIJ, Queens, Staten Island, Suffolk, Westchester, and Hudson Valley.
  • Connecticut Early Detection and Prevention ProgramminorOthersPartnership to provide free cancer screenings in Danbury and Norwalk, Connecticut for eligible individuals.

Scale indicators6 records

Recent moves7 records

Expansion highlights6 records

Northwell Cancer Institute competitors and assessment

Company assessment

Direct peers

  • City of Hope: Large NCI-designated comprehensive cancer center operating multi-site cancer programs across California, Arizona, and Illinois. Comparable in being a high-volume, multi-modality community-integrated cancer delivery network with strong research and cellular therapy programs.
  • Roswell Park Comprehensive Cancer Center: Buffalo-based standalone NCI-designated comprehensive cancer center. Comparable in being a high-volume, multi-modality cancer program with research depth, though operating in a different upstate NY geography.
  • Memorial Sloan Kettering Cancer Center: The dominant standalone cancer center in the NYC metro. Comparable in offering comprehensive medical, surgical, and radiation oncology across multiple sites, and competes directly for tertiary and complex cancer referrals that NCI also targets.
  • NYU Langone Health Perlmutter Cancer Center: NYC-based NCI-designated comprehensive cancer center offering medical oncology, radiation, surgery, CAR-T, and clinical trials across Manhattan and Brooklyn. Direct competitor for the same patient population NCI serves.
  • Mount Sinai Tisch Cancer Institute: NYC-based comprehensive cancer program offering the same modalities (radiation, surgery, immunotherapy, CAR-T, clinical trials). NCI actively hired from Mount Sinai (Kai Tsao), evidencing direct head-to-head competition for talent and patients.
  • Montefiore Einstein Cancer Center: Bronx-based NCI-designated cancer center operating as a multi-site program in the NYC metro. Overlaps with NCI on radiation, medical oncology, and surgical oncology in Westchester and the Bronx catchment.
  • NewYork-Presbyterian/Columbia Herbert Irving Comprehensive Cancer Center: NYC-based NCI-designated cancer program at Columbia. Competes for complex cases, surgical oncology, and radiation therapy referrals in the same metro as Northwell.

Regional players

  • Hackensack Meridian Health Cancer Care: New Jersey's largest cancer program and John Theurer Cancer Center partner. Comparable service breadth (radiation, surgical, cellular therapy) but primarily serves NJ patients, overlapping with NCI's NJ proton therapy partnership catchment.
  • Penn Medicine Abramson Cancer Center: Philadelphia-based NCI-designated comprehensive cancer center with comparable radiation, surgical, CAR-T, and clinical trial portfolio. Regional rather than direct competitor given geography, but comparable in scale and academic depth.

Broad incumbents

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

Northwell Cancer Institute social profiles

Digital presence

Northwell Cancer Institute compliance and trust

Trust signal

Compliance6 records

Northwell Cancer Institute financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Northwell Cancer Institute leadership team

Management profile

Number of profiles

Profiles3 records

Northwell Cancer Institute funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Northwell Cancer Institute M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Northwell Cancer Institute

What does Northwell Cancer Institute do?

Northwell Cancer Institute is a comprehensive cancer care provider offering diagnosis, treatment, and supportive services across the greater New York metropolitan area. It delivers radiation therapy, chemotherapy, immunotherapy, surgical oncology, robotic surgery, genetic counseling, cancer screening, and clinical trials through a network of hospital-based cancer centers and radiation medicine facilities.

Is Northwell Cancer Institute a public or private company?

Northwell Cancer Institute is a private company. It is classified as nonprofit foundation owned and is currently operating.

When was Northwell Cancer Institute founded?

Northwell Cancer Institute was founded in -1. It employs 11 to 50 people.

Where is Northwell Cancer Institute based?

Northwell Cancer Institute is headquartered in Lake Success, United States, in the North America region.

How does Northwell Cancer Institute make money?

Two revenue lines are on record. Cancer Treatment Services are the primary driver. The others are clinical Trials.

Who are Northwell Cancer Institute's main competitors?

Direct peers on record are City of Hope, Roswell Park Comprehensive Cancer Center, Memorial Sloan Kettering Cancer Center, NYU Langone Health Perlmutter Cancer Center, Mount Sinai Tisch Cancer Institute, Montefiore Einstein Cancer Center and NewYork-Presbyterian/Columbia Herbert Irving Comprehensive Cancer Center. Regional players are Hackensack Meridian Health Cancer Care and Penn Medicine Abramson Cancer Center. Cancer Treatment Centers of America / City of Hope Atlanta is listed as a broad incumbent.

Does Northwell Cancer Institute have an API?

No public API is recorded for Northwell Cancer Institute.

What industry is Northwell Cancer Institute in?

Northwell Cancer Institute's product category is Oncology Services. Its primary akta.pro industry code is HLAFABAI, Ambulatory Oncology Centers (Outpatient Chemo/Radiation), with a secondary code of HLAFAAAM, Hospital-Integrated Cancer Centers (Acute Oncology Programs). Its NAICS code is 62111 and its SIC code is 8093.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
GlobeNewswireNorthwell Health Cancer Institute Launches Patient Enrollment in RenovoRx’s Ongoing Pivotal Phase III TIGeR-PaC Clinical TrialNorthwell Health Cancer Institute began enrolling patients with locally advanced pancreatic cancer in RenovoRx's Phase III TIGeR-PaC trial. The trial evaluates TAMP therapy, delivering gemcitabine via RenovoCath, against standard-of-care. RenovoRx aims to complete enrollment by the first half of 2025.PR NewswireNew York City Will Walk To End Pancreatic Cancer At Its 10th Annual PurpleStride®The Pancreatic Cancer Action Network (PanCAN) is hosting its 10th Annual PurpleStride walk in New York City on April 13 to raise funds for pancreatic cancer research and patient services. The event, presented by Northwell Health Cancer Institute, aims to support critical initiatives like the Know Your Tumor program and has already seen significant community participation, with one team raising over $13,000.PR NewswireNorthwell Health Announces Sponsorship of Lustgarten Walks in NY Metro AreaNorthwell Health Cancer Institute announced it will serve as presenting sponsor for five Lustgarten Pancreatic Cancer Research Walks in the New York metropolitan area, partnering with the Lustgarten Foundation to increase awareness and fund research for pancreatic cancer, which has a nine percent five-year survival rate. Northwell and Cold Spring Harbor Laboratory have already completed their first organoid research study using patient tumors and plan to enroll patients in a nationwide organoid clinical trial funded by the Lustgarten Foundation. Northwell is also in early stages of developing a comprehensive pancreatic cancer center.PR NewswireResearchers develop new approach to radiation for prostate cancerResearchers from Northwell Health's Cancer Institute, led by Dr. Louis Potters, published a study demonstrating that higher radiation doses in stereotactic body radiation therapy (SBRT) can be safely used to treat prostate cancer with improved efficacy. The study found that the highest dose level was reached safely with little to no difference in toxicity compared to lower doses, while showing dramatic improvement in PSA values, the marker for treatment success. The researchers note this finding could serve as a foundation for future studies that may alter the current standard of care for prostate cancer treatment.